GENE ONLINE|News &
Opinion
Blog

Herceptin
Samsung Bioepis Presents 5-Year Follow-up Results on Trastuzumab Biosimilar at ESMO 2021
2021-09-13
Roche Bags EU Nod for a Novel Delivery Method in Breast Cancer Treatment
2020-12-25
Investors Back Seattle-Based Startup’s Novel Immuno-Oncology Program Targeting Solid Tumors
2020-09-26
Immunologists Receive Lasker Award Honors for the Discovery of Lymphocytes Involved in Adaptive Immunity
2019-09-25
Herceptin Hylecta bags FDA approval for HER2-Positive Breast Cancer Treatment
2019-03-04
Roche’s breast cancer drug, Kadcyla succeeds phase III trial
2018-10-22
LATEST
Healthcare Through the Eyes of AI: Coding the Future of Medicine Through Digital Acceleration
2025-03-21
European Pharmaceutical Review Highlights RNA Therapeutics and Process Analytical Technology in 2025 Issue 1
2025-03-21
Study Examines Long-Term Effects of Anti-Amyloid Drug for Rare Alzheimer’s Variant
2025-03-21
Sanofi Acquires Bispecific Drug Candidate in $600 Million Deal Focused on Autoimmune Disorders
2025-03-21
Trump Administration Policies May Impact Health Care for Intersex Individuals
2025-03-21
Federal Health Care Research Agency Faces Potential Mass Layoffs
2025-03-21
Police and Hospitals’ Drug Confiscation Practices Examined
2025-03-21
EVENT
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
Scroll to Top